IDEXX director converts 158 RSUs into common shares
IDEXX Laboratories director Joseph L. Hooley reported a routine equity compensation event.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
IDEXX Laboratories director Joseph L. Hooley reported a routine equity compensation event. On May 7, 2026, 158 restricted stock units vested and were converted into 158 shares of IDEXX common stock, with no sale involved.
Following this exercise and conversion of the derivative security, Hooley directly holds 276 shares of common stock. The vested RSUs represented a contingent right to receive one share of common stock per unit, vesting in a single installment on May 7, 2026.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 158 | $0.00 | $0.00 |
| Exercise | Common Stock | 158 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026.
- F2. Not applicable.
Key Figures
Key Terms
Restricted Stock Unit financial
derivative security financial
contingent right financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IDEXX (IDXX) director Joseph L. Hooley report?
What are the director’s IDEXX (IDXX) holdings after this Form 4 transaction?
What does the vesting of 158 restricted stock units mean for IDEXX (IDXX) director compensation?
Were any IDEXX (IDXX) derivative securities left after Joseph L. Hooley’s RSU conversion?
AI-generated analysis. How Rhea-AI works. Not financial advice.